M&G Alternatives Investment Management Limited

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
M&G Alternatives Investment Management Limited
CRD #283173
SEC #802-107608
CIK #0001891922
AUM
Employees
Phone442076264588
Address10 Fenchurch Avenue
London, United Kingdom
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Type Form D Funds Date Sold AUM
Other Infracapital Greenfield Partners II Euro SCSP 2020-03-30 1,262.7 M
Other Infracapital Greenfield Partners II Sterling SCSP 2020-03-30 779.6 M
PE Infracapital Partners III Euro SCSP [2019-03-28] 1,528.3 M 1,598.6 M
Offered $2,500,000,000 · Filed 2018-01-08 (D) · Exemption 506(b), 3(c)(7) · Minimum $1,500,000 · Remaining $971,701,000 · Duration One year or less · Commission $140,000 · Revenue Decline to Disclose
PE Infracapital Greenfield Partners I LP [2018-03-22] 19.9 M 684.4 M
Offered $19,867,550 · Filed 2017-11-20 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE Infracapital Partners Euro SCSP [2018-03-22] 1,528.3 M 1,319.6 M
Offered $2,500,000,000 · Filed 2018-01-08 (D) · Exemption 506(b), 3(c)(7) · Minimum $1,500,000 · Remaining $971,701,000 · Duration One year or less · Commission $140,000 · Revenue Decline to Disclose
PE Infracapital Partners II LP [2016-03-30] 1,544.9 M 11.6 M
Offered $2,056,000,000 · Filed 2014-10-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $10,000,000 · Remaining $511,080,803 · Duration More than one year · Commission $445,900 · Revenue Decline to Disclose
Other Infracapital Partners NT II LP 2016-03-30 330.5 M
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Milton Fernandes Director 3 2
Jonathan McClelland Director 3 2
Edward Clarke Director 3 2
Simon Pilcher Director 3 2
Anthony Ashplant Director 3 2
Grant Speirs Director 3 2
Nikolaus Roessner Director 3 2
Tautvydas Garbstas Director 1 1
Infracapital GP II Limited Executive Officer 1 1
Martin Lennon Director 1 1
Paul Rostkowski Director 1 1
Jan Fischer Director 1 1
Infracapital Partners III GP Sarl Promoter 1 1
EDGAR Form CIK 2011 - 2026
3 [0001891922]
4 [0001891922]
SC 13G [0001891922]
Form 13D/13G Filer Form 13D/13G Subject Filed
M&G Alternatives Investment Management Ltd Vaccitech PLC [2021-11-05]
Firm Profile (Form ADV)
Fund TypesPrivate Equity
LEI549300ZIIULAZVZYPH61
Form 3/4/5 Subject 2011 - 2026
M&G Alternatives Investment Management Ltd
Barinthus Biotherapeutics PLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Barinthus Biotherapeutics PLC VACC
American Depositary Shares
2022-09-30 Other 4,108,752 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com